Antiphospholipid Syndrome (APS) is a condition characterized by the occurrence of
thromboembolic events and/or pregnancy loss combined with one laboratory criterion …

Abstract Purpose of Review The aim of this review is to provide an update of the therapeutic
tools for thrombotic anti-phospholipid syndrome (APS), focusing on the last 5 years. Recent …

Antiphospholipid Syndrome (APS) is a form of immune mediated thrombophilia, presenting
as recurrent thrombotic events and pregnancy morbidity, in association with positive …

Antiphospholipid syndrome (APS) is a clinical syndrome characterized by macro-and/or
microvascular thrombosis and pregnancy morbidity, with laboratory criteria including …

The antiphospholipid syndrome (APS) is an acquired autoimmune disorder associated with
arterial, venous, or microvascular thrombosis and/or pregnancy complications mainly in …

Thrombotic manifestations of antiphospholipid syndrome are often a therapeutic dilemma
and challenge. Despite our increasing knowledge of this relatively new disease, many …

Antiphospholipid syndrome (APS) is an autoantibody-mediated acquired thrombophilia. It is
characterized by the presence of antiphospholipid antibodies (APL) that are directed against …

See also Galli M. The antiphospholipid triangle. This issue, pp 234–6. Summary
Background: The characteristics and the clinical course of antiphospholipid syndrome (APS) …

Thrombotic antiphospholipid syndrome (APS) is characterised by venous, arterial and/or
small vessel thrombosis in the context of persistently positive antiphospholipid antibodies …

The antiphospholipid syndrome (APS) is characterized by venous or arterial thrombosis
and/or pregnancy morbidity in patients with persistent presence of antiphospholipid …